Vyne Therapeutics
IPORooted in Innovation
United States · $88.2M raised
- Business Model
- B2B
- Website
- vynetherapeutics.com
- Total Funding
- $88.2M
- Last Round
- $88.2M Corporate RoundNov 2023
- Rounds
- 1
About
VYNE Therapeutics is a clinical-stage biopharmaceutical company developing therapies for inflammatory and immune-mediated diseases.
Summary
Vyne Therapeutics is a Biotech company based in United States. It has raised $88.2M in total across 1 round, most recently a $88.2M Corporate Round round in Nov 2023. Investors include Access Industries.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.